OxThera Company
OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
Funding Status:
Late Stage Venture
Headquarters:
Stockholm, Stockholms Lan, Sweden
Founded Date:
2005
Employee Number:
11-50
Last Funding Type:
Seed
Total Funding:
€4.9M
Estimated Revenue:
$10M to $50M
Industry:
PharmTech
Investors Number:
10
Technology:
Others
Investor Type:
For Profit